| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 7.154 | 100.256 | 153.572 | 141.518 | 173.669 |
| Total Income - EUR | - | - | - | - | - | 7.175 | 100.256 | 153.749 | 141.675 | 173.700 |
| Total Expenses - EUR | - | - | - | - | - | 6.497 | 97.858 | 116.993 | 110.375 | 136.229 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 678 | 2.399 | 36.756 | 31.300 | 37.471 |
| Net Profit/Loss - EUR | - | - | - | - | - | 453 | 1.399 | 34.312 | 30.049 | 30.854 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Phoenix Bioplant S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 3.198 | 35.278 |
| Current Assets | - | - | - | - | - | 55.415 | 65.191 | 121.229 | 254.216 | 295.473 |
| Inventories | - | - | - | - | - | 55.377 | 57.026 | 116.833 | 240.254 | 285.438 |
| Receivables | - | - | - | - | - | 0 | 3.038 | 4.311 | 11.414 | 7.962 |
| Cash | - | - | - | - | - | 39 | 5.127 | 86 | 2.548 | 2.072 |
| Shareholders Funds | - | - | - | - | - | 495 | 1.883 | 36.201 | 66.141 | 96.625 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 54.921 | 63.308 | 85.028 | 191.273 | 234.132 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Phoenix Bioplant S.r.l.